World News Insights
1-3 Minute Gist

All Topics Article

Study Missteps Threaten Turnaround at Schering

Wall Street Journal Original article ›

Keywords:


Vytorin study and the controversy over drug company marketing and pricing tactics.

12/17/2007

Merck sells Vytorin a combination of Zocor and Zetia for a expensive price touting benefits that may not exist according to its own study when generic Zocor can be bought for $6 for 30 days supply.

Grouped Articles

Stakes Remain High in Merck, Schering-Plough Drug Study

Wall Street Journal 12/17/2007

Drug Has No Benefit in Trial, Makers Say

New York Times 01/14/2008

Study Missteps Threaten Turnaround at Schering

Wall Street Journal 01/17/2008

Heart Group Backs Drug Made by Ally

New York Times 01/24/2008

AARP Study Says Price of Popular Drugs Rose 26%

New York Times 03/06/2012

Anemia drug made billions, but at what cost? - The Washington Post

Washington Post 07/20/2012


Support LyrArc

We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.

Support Lyrarc from as small as $1


Copyright © 2006 - 2026 Intelilinks LLC
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us